KSKaoru Sugawara

Kaoru Sugawara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kaoru Sugawara has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identifying Mild Cognitive Impairment from Routinely Collected Physical, Functional and Psychosocial Measures in Community-Dwelling Older Adults: A Comparative Machine-Learning and Regression Modelling Study in the Northern Japanese ORANGE Registry

    by Ayuto Kodama, Takako Ohnuma, Kana Sasaki, Kaoru Sugawara, Nobuhiro Fujiyama, Youko Umetsu, Tsuyoshi Ono, Hidetaka Ota

    Background: Community health check-ups routinely collect non-cognitive data. Whether these support mild cognitive impairment (MCI) triage, and whether machine learning outperforms regression, is unclear. Methods: Cross-sectional analysis of 2650 community-dwelling adults aged ≥ 65 in Akita, Japan (2018–2025). MCI was defined by the NCGG-FAT (1.5 SD, age/education-adjusted norms). Thirty-four pre-specified non-cognitive predictors were modelled using tree ensembles, penalised regression, other machine-learning families and simple reference scores, with stratified 70/30 splitting, DeLong tests, 100 repeated splits, training-derived thresholds, calibration metrics and decision-curve analysis. Results: MCI prevalence was 28.6%. Random forest discriminated best (ROC AUC 0.722, 95% CI 0.681–0.761; PR-AUC 0.542) and was well calibrated (slope 1.048; intercept −0.024), but its advantage over LASSO regression was marginal (ΔAUC +0.031, p = 0.044) and absent versus gradient boosting (p = 0.059). All multivariable models greatly outperformed the Kihon Checklist (AUC 0.550, p < 0.001). Neither operating point was deployable: at 0.5, sensitivity was 0.269 (166/227 cases missed); at the training-derived Youden threshold (0.321), sensitivity was 0.604, specificity 0.699, and PPV 0.445. Net benefit exceeded assess-all/assess-none between threshold probabilities 0.15–0.60. Conclusions: Routine non-cognitive data support moderate, well-calibrated MCI discrimination, but machine learning added little over regression. This is an exploratory triage aid requiring external validation.


  • Open Access

    The Cholinergic Receptor Nicotinic α3 Was Reduced in the Hippocampus of Early Cognitively Impaired Adult Male Mice and Upregulated by Nicotine and Cytisine in HT22 Cells

    by Hidetaka Ota, Takako Ohnuma, Ayuto Kodama, Tatsunori Shimizu, Kaoru Sugawara, Fumio Yamamoto

    Ageing is a major risk factor for cognitive and physical decline, but its mechanisms remain poorly understood. This study aimed to detect early cognitive and physical changes, and to analyze the pathway involved by monitoring two groups of mice: a young and an adult group. The study has identified the types of molecules involved in the hippocampus. Adult mice (47 weeks) showed significantly reduced exploratory behavior compared to young mice (11 weeks), although spatial working memory showed no difference. In terms of physical function, grip strength was significantly reduced in adult mice. The Frailty Index (FI) further highlighted age-related changes in adult mice. To investigate the causes of cognitive decline, adult mice were categorized based on their declining cognitive function. Microarray analysis of their hippocampi revealed that the cholinergic receptor nicotinic α3 subunit (Chrna3) was significantly reduced in mice with cognitive decline compared to controls. Subsequent in vitro experiments showed that oxidative stress and cholinesterase inhibitors decreased Chrna3 expression, whereas nicotine and cytisine increased it. These results suggest that Chrna3 is a key factor in age-related cognitive decline. The development of therapeutic strategies targeting Chrna3 expression may offer promising avenues for preclinical and clinical research to mitigate cognitive ageing.


  • Open Access

    Unmodulated 40 Hz Stimulation as a Therapeutic Strategy for Aging: Improvements in Metabolism, Frailty, and Cognitive Function in Senescence-Accelerated Prone 10 Mice

    by Tatsunori Shimizu, Hidetaka Ota, Ayuto Kodama, Yasuhiro Suzuki, Takako Ohnuma, Rieko Suzuki, Kaoru Sugawara, Yasushi Sato, Hiroyuki Kodama

    With aging populations in many countries, including Japan, efforts to mitigate the aging-related decline in physical function have gained importance not only for improving individual quality of life but also for mitigating the effects of this loss of function on society. Impaired glucose tolerance, muscle weakness, and cognitive decline are well-known effects of aging. These interrelated factors can create a vicious cycle because impaired glucose tolerance can accelerate muscle weakness and cognitive decline. Unmodulated 40 Hz (u40Hz) stimulation is imperceptible to the human ear and has been reported to improve cognitive function in humans and mice. However, research on the effects of u40Hz stimulation is still limited. This study aimed to report the effects of u40Hz stimulation on glucose tolerance and muscle strength in senescence-accelerated prone (SAMP)-10 mice, a model of accelerated aging. SAMP-10 mice underwent five weeks of u40Hz stimulation followed by glucose-tolerance tests, cognitive and behavioral assessments, and frailty evaluations. In comparison with the control group, the u40Hz-stimulation group showed mitigation of age-related decline in glucose tolerance, a better frailty index (FI), and notably preserved muscle strength. Microarray analysis of stimulated muscle tissue revealed significant upregulation of β-oxidation genes and genes functioning downstream of peroxisome proliferator-activated receptor gamma, and significant downregulation of clock genes. These findings indicate the beneficial effects of u40Hz stimulation on glucose tolerance, muscle strength, and cognitive function, warranting further research in this area.